📣 VC round data is live. Check it out!

AdaptHealth Valuation Multiples

Discover AdaptHealth's revenue and EBITDA valuation multiples and M&A history, alongside public comparables like AtriCure, Wandong Medical, Sinocare, SonoScape and more.

AdaptHealth Overview

About AdaptHealth

AdaptHealth Corp is engaged in providing patient-centered, healthcare-at-home solutions including home medical equipment (HME), medical supplies, and related services. The Company operates under four reportable segments that align with its product categories: (i) Sleep Health, (ii) Respiratory Health, (iii) Diabetes Health, and (iv) Wellness at Home. The company generates majority of its revenue from the Sleep Health segment. The Sleep Health segment provides sleep therapy equipment, supplies and related services (including continuous positive airway pressure and BiLevel services) to individuals for the treatment of obstructive sleep apnea.


Founded

2017

HQ

United States

Employees

10.9K

Financials (LTM)

Revenue: $3B
EBITDA: $650M

EV

$3B

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

AdaptHealth Financials

AdaptHealth reported last 12-month revenue of $3B and EBITDA of $650M.

In the same LTM period, AdaptHealth generated $709M in gross profit, $650M in EBITDA, and $5M in net income.

Revenue (LTM)


AdaptHealth P&L

In the most recent fiscal year, AdaptHealth reported revenue of $3B and EBITDA of $617M.

AdaptHealth is unprofitable as of last fiscal year, with gross margin of 19%, EBITDA margin of 19%, and net margin of (2%).

See analyst estimates for AdaptHealth
LTMLast FY202320242025202620272028
Revenue$3B$3B$3B$3B$3B
Gross Profit$709M$609M$480M$681M$609M
Gross Margin21%19%15%21%19%
EBITDA$650M$617M($211M)$628M$473M
EBITDA Margin19%19%(7%)19%15%
EBIT Margin8%7%7%8%6%
Net Profit$5M($71M)($679M)$90M($71M)
Net Margin0%(2%)(21%)3%(2%)
Net Debt-$2B---

Financial data powered by Morningstar, Inc.

AdaptHealth Stock Performance

AdaptHealth has current market cap of $1B, and enterprise value of $3B.

Market Cap Evolution


AdaptHealth's stock price is $9.65.

AdaptHealth share price decreased by 4.8% in the last 30 days, and increased by 2.6% in the last year.

AdaptHealth has an EPS (earnings per share) of $-0.52.

See more trading valuation data for AdaptHealth
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$3B$1B-2.6%-4.8%-18.9%2.6%$-0.52

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

AdaptHealth Valuation Multiples

AdaptHealth trades at 1.0x EV/Revenue multiple, and 5.0x EV/EBITDA.

See NTM and 2027E valuation multiples for AdaptHealth

EV / Revenue (LTM)


AdaptHealth Financial Valuation Multiples

As of June 3, 2026, AdaptHealth has market cap of $1B and EV of $3B.

AdaptHealth has a P/E ratio of 250.9x.

LTMLast FY202320242025202620272028
EV/Revenue1.0x1.0x1.0x1.0x1.0x
EV/EBITDA5.0x5.3x(15.5x)5.2x6.9x
EV/EBIT13.0x13.9x14.1x11.8x17.5x
EV/Gross Profit4.6x5.4x6.8x4.8x5.4x
P/En/m(18.6x)(1.9x)14.5x(18.6x)
EV/FCF16.8x14.9x22.8x13.9x14.9x

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified AdaptHealth Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

AdaptHealth Margins & Growth Rates

AdaptHealth grew revenue by 7% and EBITDA by 13% in the last fiscal year.

In the most recent fiscal year, AdaptHealth reported gross margin of 19%, EBITDA margin of 19%, and net margin of (2%).

See estimated margins and future growth rates for AdaptHealth

AdaptHealth Margins

Last FY202420252026202720282029
Gross Margin19%21%19%21%
EBITDA Margin19%19%15%20%
EBIT Margin7%8%6%8%
Net Margin(2%)3%(2%)3%
FCF Margin7%7%7%5%

AdaptHealth Growth Rates

FY+1/FY23/2424/2525/2626/2727/2828/29
Revenue Growth7%2%(0%)7%
Gross Profit Growth22%42%(11%)22%
EBITDA Growth13%(398%)(25%)47%
EBIT Growth17%19%(33%)48%
Net Profit Growth(255%)(113%)(178%)(255%)
FCF Growth(27%)65%(7%)(27%)

Data powered by FactSet, Inc. and Morningstar, Inc.

AdaptHealth Operational KPIs

AdaptHealth's revenue per employee in the last FY averaged $0.3M, while opex per employee averaged $0.0M for the same period.

AdaptHealth's Rule of 40 is 27% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

AdaptHealth's Rule of X is 38% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

Access forward-looking KPIs for AdaptHealth
LTMLast FY202320242025202620272028
Rule of 4026%27%---
Bessemer Rule of X37%38%---
Revenue per Employee-$0.3M---
Opex per Employee-$0.0M---
G&A Expenses to Revenue11%12%6%11%12%
Opex to Revenue-13%8%12%13%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

AdaptHealth Competitors

AdaptHealth competitors include AtriCure, Wandong Medical, Sinocare, SonoScape, VCANBIO, Tandem Diabetes Care, Enovis, Nolato, Poly Medicure and Nihon Kohden.

Most AdaptHealth public comparables operate across Medical Devices, DeepTech and HealthTech.

EV/RevenueEV/EBITDA
Last FYLTM2027ELast FYLTM2027E
AtriCure2.3x2.2x20.0x17.7x
Wandong Medical4.5x4.3x(24.0x)-
Sinocare1.9x1.8x22.4x17.2x
SonoScape3.3x3.1x27.8x24.6x
VCANBIO5.1x-22.3x-
Tandem Diabetes Care1.4x1.4x(31.2x)(430.9x)
Enovis1.2x1.2x6.6x6.4x
Nolato1.4x1.4x8.5x8.5x

This data is available for Pro users. Sign up to see all AdaptHealth competitors and their valuation data.

Start Free Trial

AdaptHealth VC Funding History

Before going public, AdaptHealth raised $2M in total equity funding, across 1 round.


AdaptHealth Funding Rounds

DateStageRaised FromRaisedValuationRev. MultipleDeal Summary
Nov-17SeedKinled Holding$2M--

Acquisitions by AdaptHealth

AdaptHealth has acquired 5 companies to date.

Last acquisition by AdaptHealth was on May 24th 2021. AdaptHealth acquired Spiro Health for undisclosed valuation.

See M&A valuation multiples

Latest Acquisitions by AdaptHealth

Spiro Health
Pinnacle Medical Solutions
Aerocare Holdings
ActivStyle
Description
Spiro Health is a patient-focused home medical equipment provider specializing in sleep therapy and respiratory care across Virginia, Washington DC, Maryland, Connecticut, Rhode Island, Massachusetts, New Hampshire, and Maine. It supplies CPAP machines, oxygen concentrators, ventilators, and nebulizers with delivery, setup, and compliance monitoring services. Operating from Chantilly headquarters, Spiro Health partners with hospitals for post-acute transitions and telehealth support.
Pinnacle Medical Solutions is a Southaven, Mississippi-based distributor of diabetes supplies including glucose meters, test strips, and insulin pumps delivered directly to patients' homes. The company partners with insurers like Humana and manufactures like Abbott to serve over 50,000 patients annually across 20 US states. Services include patient training via telehealth and compliance reporting for Medicare Advantage plans. Established in 2006, Pinnacle maintains warehouses in Memphis and ships via FedEx to rural areas.
Aerocare Holdings is a durable medical equipment provider specializing in respiratory therapy from its Coral Springs, Florida headquarters. It supplies home oxygen concentrators, CPAP machines, nebulizers, and cleaning supplies for patients with COPD, CHF, and sleep apnea. The company serves Medicare beneficiaries across multiple U.S. states through direct delivery and setup services.
ActivStyle is a medical supplies distributor offering home delivery of home healthcare products including mobility aids, wound care, and incontinence supplies. Headquartered in the United States, the company serves individual patients, healthcare providers, and case managers with personalized service backed by a leadership team holding nearly 100 years of combined industry experience from major American healthcare organizations.
HQ CountryUnited StatesUnited StatesUnited StatesUnited States
HQ City
-
Memphis, TN
Orlando, FL
Minneapolis, MN
Deal Date24 May 20213 Dec 20201 Dec 202026 May 2020
Valuationundisclosed$130M$2B$62M
EV/Revenue
EV/EBITDA

This data is available for Pro users. Sign up to see all AdaptHealth acquisitions and their M&A valuation multiples.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About AdaptHealth

When was AdaptHealth founded?AdaptHealth was founded in 2017.
Where is AdaptHealth headquartered?AdaptHealth is headquartered in United States.
How many employees does AdaptHealth have?As of today, AdaptHealth has over 10K employees.
Who is the CEO of AdaptHealth?AdaptHealth's CEO is Suzanne M. Foster.
Is AdaptHealth publicly listed?Yes, AdaptHealth is a public company listed on Nasdaq.
What is the stock symbol of AdaptHealth?AdaptHealth trades under AHCO ticker.
When did AdaptHealth go public?AdaptHealth went public in 2018.
Who are competitors of AdaptHealth?AdaptHealth main competitors include AtriCure, Wandong Medical, Sinocare, SonoScape, VCANBIO, Tandem Diabetes Care, Enovis, Nolato, Poly Medicure, Nihon Kohden.
What is the current market cap of AdaptHealth?AdaptHealth's current market cap is $1B.
What is the current revenue of AdaptHealth?AdaptHealth's last 12 months revenue is $3B.
What is the current revenue growth of AdaptHealth?AdaptHealth revenue growth (NTM/LTM) is 7%.
What is the current EV/Revenue multiple of AdaptHealth?Current revenue multiple of AdaptHealth is 1.0x.
What is the current EBITDA of AdaptHealth?AdaptHealth's last 12 months EBITDA is $650M.
What is AdaptHealth's EBITDA margin?AdaptHealth's last 12 months EBITDA margin is 19%.
What is the current EV/EBITDA multiple of AdaptHealth?Current EBITDA multiple of AdaptHealth is 5.0x.
What is the current FCF of AdaptHealth?AdaptHealth's last 12 months FCF is $194M.
What is AdaptHealth's FCF margin?AdaptHealth's last 12 months FCF margin is 6%.
What is the current EV/FCF multiple of AdaptHealth?Current FCF multiple of AdaptHealth is 16.8x.
How many companies AdaptHealth has acquired to date?As of June 2026, AdaptHealth has acquired 5 companies.
What was the largest acquisition by AdaptHealth?$2B acquisition of Aerocare Holdings on 1st December 2020 was the largest M&A AdaptHealth has done to date.
What companies AdaptHealth acquired?AdaptHealth acquired Aerocare Holdings, Solara Medical Supplies, Pinnacle Medical Solutions, ActivStyle, and Spiro Health.
In how many companies AdaptHealth has invested to date?AdaptHealth hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to AdaptHealth

Lists including AdaptHealth

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial